B Braun to enter drug-coated stent market
This article was originally published in Clinica
Executive Summary
German company B Braun Melsungen, which manufactures healthcare products for hospitals and the non-clinical sector, has signed a co-operative agreement with fellow German company Rodleben Pharma, to develop drug-coated stents.